Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Thomas Aparicio

PUPH

Assistance Publique - Hôpitaux de Paris

France

Research Interests

Explore related searches

Professors in France Professors in Epidemiology Epidemiology professors in France

Articles (14)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (8)

Thierry André

Sorbonne Université

FRANCE

View details

David Malka

Head, gastrointestinal tumor group

Gustave Roussy

FRANCE

View details

Anthony Turpin

Centre Hospitalier Régional Universitaire de Lille

FRANCE

View details

david tougeron

FRANCE

View details

Maximiliano Gelli

Chief of Department, HPB Surgeon

Institut Gustave Roussy

FRANCE

View details

Jean-Luc Raoul

Prof

Institut de Cancérologie de l'Ouest

FRANCE

View details

Come Lepage

Université de Bourgogne

FRANCE

View details

Pierre Laurent-Puig

Université Paris Descartes

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas Aparicio

Research Interests

Explore related searches

Articles (14)

Predicting severe toxicities and mortality in older patients with colorectal cancer: An analysis of 3 clinical trials and 3 prospective cohorts.

Small bowel adenocarcinoma

Efficacy of targeted therapies for metastatic small bowel adenocarcinoma treatment: A retrospective study by AGEO

Humanized avian embryo models replicate an immune tumor environment for rapid immunotherapy studies

FOLFIRINOX or FOLFOX for locally advanced or metastatic small bowel adenocarcinoma: PRODIGE 86 – FFCD-GONO – ENGIC 02 – FOLFIRINOX SBA phase II randomized trial

Geriatric Assessment and Management, Prehabilitation and Rehabilitation for Older Aldults with Non-Colorectal Digestive Cancers

First-Line LV5FU2 with or without Aflibercept in Patients with Non-Resectable Metastatic Colorectal Cancer: A Randomized Phase II Trial (PRODIGE 25-FFCD-FOLFA)

How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive Oncology

Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases

Results of complete cytoreductive strategy in patients with peritoneal metastases of colorectal origin with or without extraperitoneal metastases: A bicentric analysis.

Trifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ± nivolumab in HER2 negative advanced oesogastric adenocarcinoma: The PRODIGE73-UCGI40-LOGICAN trial

Management of esogastric cancer in older patients

Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancer

Molecular profiling of anal Paget’s disease and underlying anal adenocarcinoma highlights their common origin

Collaborators (8)

Thierry André

David Malka

Anthony Turpin

david tougeron

Maximiliano Gelli

Jean-Luc Raoul

Come Lepage

Pierre Laurent-Puig

Make your next move.